HUTCHMED (China) (HMDCF) Goodwill & Intangibles (2014 - 2025)
HUTCHMED (China)'s (HMDCF) quarterly Goodwill & Intangibles came in at $12.1 million in Q4 2025, up 303.11% year-over-year from $3.0 million in Q4 2024, and up 24.94% quarter-over-quarter from $9.6 million in Q2 2025.
Analysis
HUTCHMED (China) (HMDCF) Goodwill & Intangibles (2014 - 2025) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Goodwill & Intangibles for 12 consecutive years, with $12.1 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Goodwill & Intangibles rose 303.11% year-over-year to $12.1 million in Q4 2025; TTM through Dec 2025 was $12.1 million, a 303.11% increase from a year earlier, with the FY2025 full-year figure at $12.1 million, up 303.11% from the prior year.
- Goodwill & Intangibles was $12.1 million for Q4 2025 at HUTCHMED (China), up from $9.6 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $12.1 million in Q4 2025 and troughed at $21000.0 in Q4 2023.
- A 5-year average of $3.2 million and a median of $194000.0 in 2021 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles tumbled 97.6% in 2022 and surged 14138.1% in 2024, its largest moves.
- Over 5 years, Goodwill & Intangibles stood at $3.5 million in 2021, then plunged by 97.6% to $85000.0 in 2022, then sank by 75.29% to $21000.0 in 2023, then surged by 14138.1% to $3.0 million in 2024, then surged by 303.11% to $12.1 million in 2025.
- The last three Goodwill & Intangibles figures came in at $12.1 million (Q4 2025), $9.6 million (Q2 2025), and $3.0 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 12.05 Mn |
| Jun 30, 2025 | 9.65 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Dec 31, 2023 | 21,000.00 |
| Jun 30, 2023 | 52,000.00 |
| Dec 31, 2022 | 85,000.00 |
| Jun 30, 2022 | 122,000.00 |
| Dec 31, 2021 | 3.54 Mn |
| Jun 30, 2021 | 194,000.00 |
| Dec 31, 2020 | 3.53 Mn |
| Jun 30, 2020 | 241,000.00 |
| Dec 31, 2019 | 3.39 Mn |
| Sep 30, 2019 | 288,000.00 |
| Jun 30, 2019 | 315,000.00 |
| Mar 31, 2019 | 340,000.00 |
| Dec 31, 2018 | 3.53 Mn |
| Jun 30, 2018 | 403,000.00 |
| Dec 31, 2017 | 3.74 Mn |
| Jun 30, 2017 | 445,000.00 |
| Dec 31, 2016 | 3.61 Mn |